Member Info for MadEnglish

Aptamer Group is already working with several major players in the pharmaceutical industry:

The company has contracts with all of the top 10 global pharmaceutical companies.

It has secured multiple repeat contracts and expanded partnerships with a "top five" and "top three" global pharmaceutical company for various projects, including radiopharmaceuticals and neurology drug targets.

Publicly named partners include AstraZeneca and Japan's Takeda.

These ongoing fee-for-service contracts allow Aptamer Group to retain the future licensing and royalty rights to the intellectual property it develops, which creates high-value licensable assets. The consistent repeat business and the strong validation of its Optimer platform indicate that a large pharmaceutical partner might view a direct equity stake as a logical next step to secure long-term value, intellectual property, or potential acquisition targets.

While the company currently operates primarily through contracts and collaborations, the potential for future licensing deals and the strategic value of its technology make it a plausible target for a larger investment or takeover as it positions itself for sustained growth.

For some results and / or a continued rise this week.

ATB

ME

I hear you S/C, I'm sort of hoping it's a slow start to the week so I can grab a few before we get into unchartered territory.

ATB

ME

Https://uk.advfn.com/market-news/article/1468/aptamer-group-secures-2-million-to-accelerate-optimer-technology-rollout

How they're using AI:

AI-Enhanced Development: They are developing in-house expertise and using AI/ML to create new aptamer sequences with multiple desirable "drug-like" properties.

Accelerated Discovery: Their AI-powered platform generates novel aptamer sequences, bypassing limitations of traditional bioinformatics and speeding up the process compared to lab-based methods like SELEX.

Integrated Approach: They combine AI with their high-throughput Optimer® platform for automated discovery, identifying aptamers for proteins, small molecules, and even cells, saving significant time and money.

New Services: Funds are being used to launch new services, including AI-enhanced biomarker discovery, to find targets and generate aptamers simultaneously, notes ADVFN UK.

In essence, Aptamer Group is leveraging AI to make aptamer development more creative, faster, and commercially viable for applications in diagnostics and therapeutics, say Cancer Research Horizons and ScienceDirect.com.

Happy New Year to all of us here.

ME

ATB and a VERY HAPPY NEW YEAR for all investors and all at Aptamer-Group .

ME

Hi Ant

I wouldn't say that that's a controversial assessment, in fact if you look at the forecasts for Aptamer-Group on A.I you could be accused of woefully under valuing them at 10p.

Anyway, much like Freddie and yourself I will continue to add as and when funds are available.

ATB and a VERY HAPPY NEW YEAR for all investors and all at Aptamer-Group .

ME

Merry Xmas to one and all of us and to all at Aptamer-Group. Looking forward to 2026.

ME.

You were correct Freddie, it was bobber being negative

Shareholders having a pop at the board on their Xmas Party post.

Not that we'll get a response but they need to hear it. Where's this 'significant and tangible' progress then ?

Trying to stay positive and upbeat, honestly! 😁

All the Best to all holders at Christmas and going forward...

ME

Llama let's hope so, it's clear the UK markets put no value in small pharna.

ATB

ME

Surprisingly quiet on here with this RNS.

ATB

ME

Morning Freddie, Yeah when we turned blue yesterday I really thought we'd see that Red Dot this morning. Nevermind, just like Xmas it's on it's way.

ME

That usually doesn't stop them on these LSE Boards 🤣😂

Anytime now, all the best for the week ahead.

ME

Https://www.mining.com/web/cochilco-hikes-2025-2026-copper-price-forecasts-to-record-highs/

Marty, I'm not following you there. Apologies if I'm being a bit thick

ME

To a great week ahead !

ATB

ME

I was quite positive on this and ignoring a lot of the negativity but just looking over LinkedIn this morning it does feel like a little club for 3 or 4 individuals with cryptic postings but no actual meat on the bones. Very 'Closed Shop' feeling ( for me at least)

All the best regardless.

ME